Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 3, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Dry Eye Disease (DED)
Interventions
DEVICE

Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML

Prospective, single-site, single-arm study enrolling 60 patients who have elected advanced IOL implantation at the time of cataract surgery and have a diagnosis of dry eye disease. The study will consist of 5 study visits, over a 3-5 month time period. Patients will receive bilateral lacrimal occlusion of crosslinked hyaluronate canalicular gel pre-operatively

Trial Locations (1)

57105

RECRUITING

Vance Thompson Vision Clinic, Prof. LLC, Sioux Falls

All Listed Sponsors
lead

Vance Thompson Vision

OTHER

NCT07155057 - Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery | Biotech Hunter | Biotech Hunter